Biogen Inc. Common Stock (BIIB) Financials

Key financial figures for Biogen Inc. Common Stock (Q1 2026).

Revenue
$2.5B
Net Income
$320M
EPS
$2.17
Total Assets
$29.5B
Operating Cash Flow
$646M

Full income statement, balance sheet, and cash flow for Biogen Inc. Common Stock on SentiSense.